Registration now open for first Biopharmaceutical Manufacturing Interest Group meeting Dec. 3

Thursday, Dec. 3, 2020
10:00–11:00 a.m.

BTEC and NC State's Office of Research and Innovation (ORI) have announced the formation of the Biopharmaceutical Manufacturing Interest Group (BMIG), which will hold its first meeting 10:00–11:00 a.m. Thursday, Dec. 3. Those interested in attending may register online for the virtual meeting.

BMIG was established to help address the challenges facing biopharmaceutical manufacturing. Its aim is to develop a strong collaborative network of experts in the field of biopharmaceutical manufacturing from various disciplines and institutions within the UNC system and from industry. The group’s goal is to leverage NC State’s strengths to form collaborative teams to brainstorm and respond to large joint proposals in the field of biopharmaceutical manufacturing. The BMIG website provides additional information about the group and how to join.

The Dec. 3 virtual meeting will include remarks by BMIG’s leadership team and a question-and-answer session. The following individuals lead the group:

  • Dr. Ruben Carbonell, Senior Technology Strategist, National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL); Frank Hawkins Kenan Distinguished Professor, Chemical and Biomolecular Engineering
  • Dr. Jonathan Horowitz, Associate Vice Chancellor, Office of Research and Innovation
  • Dr. Gary Gilleskie, Executive Director, BTEC
  • Dr. Jennifer Pancorbo, Director, Industry Programs and Research, BTEC

Biopharmaceutical manufacturing is a major component of the NC economy and a hub of NC State’s efforts in advanced manufacturing. BTEC is a global leader in biomanufacturing workforce development and research and plays an important leadership role in the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

For more information about BMIG, see the group’s website or email Dr. Deepa Sambandan, BTEC's research program manager.